Skip to content
WeighLab
Menu
Ranked #186 · Grade C

Zeuss review

Zeuss (Zeuss LLC) is a compounded-GLP-1 telehealth brand marketed around avoiding 'subscription traps' — its FAQ states there are 'no recurring charges or automatic refills,' i.e.

Visit Zeuss Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$125/mo (starting dose, compounded)
Tirzepatide
$175/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$1,500

Tirzepatide · modeled / year

$2,100

Pricing verified August 2026

The Index scorecard

Zeuss scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month78/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options79/100
Clinical Oversight52/100
Contract Flexibility61/100

Where the value is

  • Genuinely no-subscription billing confirmed in its own FAQ ('no recurring charges or automatic refills') — patients pay per order, not a locked recurring plan
  • LegitScript certified, with the badge and verification link displayed on the homepage
  • States it 'partners exclusively with 503A and 503B state-licensed compounding pharmacies'
  • Explicitly positions itself for maintenance-dose patients, a use case most peer sites ignore

The tradeoffs

  • Both $125 and $175 are 'starting at' prices with no disclosed dose (mg) or confirmation the price holds at higher/titrated doses
  • No compounding pharmacy is named, only 'licensed partner pharmacy'
  • No named medical director or individual prescriber anywhere on the site
  • No states-served list published; its only public address (Wilmington, DE) is a registered-agent address, not an operating office — a real transparency gap for a company handling prescription medication
  • FDA issued Zeuss LLC dba Zeuss a warning letter in February 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Patients already stable on a maintenance GLP-1 dose who want to pay per fill instead of a subscription. Zeuss (Zeuss LLC) is a compounded-GLP-1 telehealth brand marketed around avoiding 'subscription traps' — its FAQ states there are 'no recurring charges or automatic refills,' i.e.

Ranked #186 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Zeuss.

The 24 programs nearest this one

Pricing, states and verification reflect Zeuss's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Zeuss's site. Not medical advice; see our disclosure.

← Back to the value leaderboard